KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northrop Grumman (NOC) Other Accumulated Expenses (2016 - 2026)

Northrop Grumman (NOC) has disclosed Other Accumulated Expenses for 18 consecutive years, with $4.7 billion as the latest value for Q1 2026.

  • For Q1 2026, Other Accumulated Expenses fell 23.52% year-over-year to $4.7 billion; the TTM value through Mar 2026 reached $4.7 billion, down 23.52%, while the annual FY2025 figure was $4.2 billion, 18.14% down from the prior year.
  • Other Accumulated Expenses was $4.7 billion for Q1 2026 at Northrop Grumman, up from $4.2 billion in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $6.2 billion in Q1 2025, with the low at $2.4 billion in Q1 2022.
  • Historically, Other Accumulated Expenses has averaged $4.2 billion across 5 years, with a median of $4.2 billion in 2025.
  • The largest annual shift saw Other Accumulated Expenses dropped 24.84% in 2023 before it skyrocketed 106.84% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $3.3 billion in 2022, then increased by 1.62% to $3.4 billion in 2023, then surged by 53.13% to $5.2 billion in 2024, then decreased by 18.14% to $4.2 billion in 2025, then rose by 10.93% to $4.7 billion in 2026.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $4.7 billion in Q1 2026, $4.2 billion in Q4 2025, and $4.4 billion in Q3 2025.